Monireh Mohsenzadegan

12PUBLICATIONS
5CO-AUTHORS
Cancer diagnosisMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Forestry biomass and bioproductsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 14, 2024
Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors.

Parisa Bakhshi, Maryam Nourizadeh, Laleh Sharifi

|Jun 14, 2022
The prospect of targeting T cell immunoglobulin and mucin-domain containing-3 in renal cell carcinoma immunotherapy.

Monireh Mohsenzadegan, Mohammad Reza Nowroozi, Amirreza Fotovvat

|Apr 04, 2022
Efficacy of immunotherapy in obese patients with cancer.

Yasaman Mojibi, Farhad Seif, Nastaran Mojibi

|Mar 25, 2022
Enhancing of Wound Healing in Burn Patients through Candida albicans β-Glucan.

Fateme Abedini, Shahla Roudbar Mohammadi, Mostafa Dahmardehei

|May 31, 2021
Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell.

Monireh Mohsenzadegan, Fatemeh Moghbeli, Abbas Mirshafiey

|Dec 14, 2020
Clinical significance of peripheral blood CD11b+/CD33+/HLA-DR- myeloid cells in infants and children with infectious diseases and increased CRP.

Aysan Latifi, Samad Ghanizadeh-Vesali, Soudabeh Hosseini

Pageof 2